Medical Oncologist
CION Cancer Clinics
CDKN2A and the pancreas: the risk, and how carriers are watched | CION Cancer Clinics
A fault in the CDKN2A gene raises the risk of pancreatic cancer, even in families where no one has had it yet. The rise is large compared with the general population, but most carriers never develop the disease. This page explains why the pancreas is affected, what makes the risk higher or lower, what surveillance can and cannot do, and what to watch for between checks. At CION Cancer Clinics, our oncologists explain what a gene result means for you and your family, and plan the checks that follow.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- Does a CDKN2A fault raise pancreatic cancer risk?
- What makes one carrier's risk higher than another's?
- What does pancreatic surveillance involve?
- What do the words in a pancreas report mean?
- What surveillance can do, and what it cannot
- What this page cannot tell you
- Four things carriers are told, and what is true
- Common questions about CDKN2A and the pancreas
The short answer
Does a CDKN2A fault raise pancreatic cancer risk?
Yes. A harmful change in CDKN2A raises the lifetime risk of pancreatic cancer well above that of the general population. It does this even in families where nobody has had pancreatic cancer yet. Most carriers still never develop it, but the rise is large enough that carriers are usually offered regular checks of the pancreas.
Why the pancreas is hard to watch
The pancreas sits deep in the upper abdomen, behind the stomach. Early cancers there rarely cause symptoms, and there is no simple blood test that finds them reliably. By the time most people feel unwell, the cancer has often spread. That is the reason carriers are watched with scans rather than waiting for symptoms.
Why a family history is not needed
For most genes, pancreatic surveillance is offered only when a relative has already had pancreatic cancer. CDKN2A is one of the few exceptions. International expert groups consider carriers eligible for surveillance on the strength of the gene alone.
A raised risk is a reason to be watched. It is not a diagnosis.Higher or lower
What makes one carrier's risk higher than another's?
The gene sets a raised starting point. Several other things move it up or down from there.
Tobacco in any form
Smoking raises pancreatic cancer risk in everyone, and in CDKN2A carriers the effect appears stronger. Beedis and chewed tobacco count too. Stopping lowers the risk over time, at any age.
Pancreatic cancer in relatives
Each close relative who had pancreatic cancer pushes the family's estimate higher. A relative diagnosed young usually means checks start earlier.
The exact change in the gene
Not every CDKN2A fault behaves the same. Some changes studied in large European families carry a higher pancreatic risk than others. For most variants found in Indian families, there is simply not enough data yet.
Risks everyone shares
These add to the gene's effect rather than replacing it.
- Long-standing diabetes
- Carrying a lot of extra weight
- Heavy drinking
- Repeated inflammation of the pancreas
Not sure whether this applies to you?
Ask an oncologistBeing watched
What does pancreatic surveillance involve?
A referral to an experienced team
Surveillance works best where gastroenterologists, radiologists and surgeons see many high-risk people and review scans together. Your counsellor or oncologist makes the referral.
A starting age is agreed
Expert groups usually suggest starting around the age of forty for CDKN2A carriers, or earlier if a relative was diagnosed young. Your team will set the age for you.
The scan itself
Usually an MRI of the pancreas, which uses no radiation, or an endoscopic ultrasound, where a thin camera passes through the mouth under sedation. Many programmes use both.
A blood sugar check
Diabetes that appears suddenly can be an early sign of a pancreatic problem, so blood sugar is usually checked alongside the scan.
Results and the next date
If all is clear, the check is usually repeated once a year. If something small is seen, the next scan may come sooner, and the team explains why.
On your letters
What do the words in a pancreas report mean?
- Pancreas
- A gland behind the stomach that makes digestive juices and the hormone insulin, which controls blood sugar.
- Adenocarcinoma
- The common type of pancreatic cancer, starting in the cells lining the small ducts. This is what CDKN2A mainly raises the risk of.
- MRCP
- A type of MRI scan that shows the pancreas and its ducts in detail. It uses a magnet, not radiation.
- Endoscopic ultrasound
- An ultrasound probe on a thin tube passed into the stomach under sedation. It sits right beside the pancreas and can take a sample.
- Cyst
- A small fluid-filled sac. Most pancreatic cysts are harmless. A few types are watched because they can change over time.
- Germline
- Present in every cell from birth, and able to pass to children. A change found only in a tumour sample is a different finding.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Side by side
What surveillance can do, and what it cannot
Surveillance can
Surveillance cannot
Find some cancers while they are still small
Promise that every cancer is caught early
Spot some changes before they become cancer
Say which small cysts will ever matter
Give a planned, regular check
Replace attention to new symptoms between scans
Use MRI, which carries no radiation
Avoid the occasional false alarm and extra test
Lead to timely surgery when needed
Remove the underlying inherited risk
Being straight with you
What this page cannot tell you
It cannot give you your own risk figure. That depends on your exact variant, your family tree and your habits. What your specific variant means is a question for the counsellor who ordered the test.
A tumour report is a different thing
Changes in CDKN2A are found inside most pancreatic tumours, because the gene is often damaged as the cancer grows. If your relative's tumour report mentions CDKN2A, that usually says nothing about the family. Only a blood or saliva test for inherited faults answers the family question. Tumour testing belongs with our targeted therapy pages.
Who this does not apply to
Most people with one relative who had pancreatic cancer do not carry a CDKN2A fault and do not need pancreatic surveillance. A single pancreatic cancer in an older relative who smoked or drank heavily rarely points to this gene. A counsellor is as willing to tell you that as to recommend a test.
Where the evidence is thin
Whether surveillance helps carriers live longer is still being studied. The early signs are encouraging, but the studies are small and mostly from outside India.
Commonly believed
Four things carriers are told, and what is true
"Pancreatic cancer is always found too late, so there is no point looking."
It is usually found late in people who are not being watched. In expert programmes, cancers found through surveillance are more often at a stage where surgery is possible.
"A normal CA 19-9 blood test means my pancreas is fine."
This blood marker misses many early cancers and can be raised for other reasons. It is not reliable for screening on its own, which is why imaging is used.
"Only people who drink get pancreatic cancer."
Heavy drinking is one risk among several. Tobacco, diabetes and inherited faults such as CDKN2A matter too, and many patients never drank at all.
"I feel perfectly well, so I can skip this year's scan."
Early pancreatic cancer causes no symptoms. Feeling well is exactly the situation surveillance was designed for.
Questions we are asked
Common questions about CDKN2A and the pancreas
At what age does surveillance usually start?
Expert groups usually suggest starting around the age of forty for CDKN2A carriers. It may start earlier if a relative was diagnosed young. Your counsellor and gastroenterologist set the age for you, using your family tree rather than a single rule.
Is MRI or endoscopic ultrasound better?
Each has strengths. MRI needs no sedation and no radiation, and shows the whole pancreas. Endoscopic ultrasound gives a closer view of small areas and can take a sample. Many programmes alternate between them or combine them, depending on what earlier scans showed.
Which symptoms should a carrier never ignore?
Yellow eyes or skin, dark urine, pale stools, weight loss you cannot explain, diabetes that appears suddenly, or pain in the upper abdomen spreading to the back. See a doctor promptly and mention your CDKN2A result. Do not wait for the next planned scan.
Does stopping smoking now still help?
Yes. The extra risk from smoking falls after you stop, whatever your age. For a CDKN2A carrier, giving up all tobacco, including beedis and chewed tobacco, is the single change most likely to lower pancreatic risk. Ask your doctor about help to quit.
Is a CT scan used for surveillance?
Not usually for routine checks. CT uses radiation, which adds up over many years of screening. It is more often used when surveillance has already found something that needs a closer look, or when MRI is not possible.
Where can I have pancreatic surveillance in Hyderabad?
At larger centres with experienced gastroenterology and radiology teams who see high-risk patients regularly. Staying with one centre helps, because the same team compares each scan with the last. CION can help arrange a referral.
Can surgery remove the risk before cancer starts?
Removing a healthy pancreas is not offered as a preventive step. It would cause lifelong diabetes and digestion problems. Surgery is considered only when surveillance finds something worrying, and your team will discuss it as one option among several.
Should my children be tested now?
Pancreatic risk is an adult concern, so testing for this reason usually waits until a child is grown up and can decide for themselves. Sun protection and skin care still apply to children in a carrier family. Your counsellor will explain the right timing.
Your Specialists
Meet CION's oncologists. Bring your family history or genetic report to them.
Our medical oncologists see people with a strong family history of cancer, arrange genetic counselling and testing where it fits, and plan the checks that follow.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- MedlinePlus Genetics — CDKN2A gene
- MedlinePlus Genetics — Pancreatic cancer
- National Cancer Institute — Pancreatic Cancer Screening (PDQ) – Patient Version
- Cancer Research UK — Risks and causes of pancreatic cancer
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
CDKN2A mutation: which cancers and what riskMelanoma, the pancreas and the weaker linksSurveillance for CDKN2A carriersSkin and pancreas checks in one schedulePancreatic surveillance: who qualifiesHow pancreas screening works across all genesWhere pancreatic surveillance is availableFinding an experienced team near Hyderabad
Talk to us
Carrying CDKN2A and unsure about pancreas checks?
Tell us about your result and your family history. We will explain whether pancreatic surveillance fits your situation and help arrange it with an experienced team. One helpline serves every CION centre.